Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement - Arefi, Maryam; García, Juan L.; Peñarrubia, María J.; Queizán, José A.; Hermosín, Lourdes; López-Corral, Lucía; Megido, Marta; Giraldo, Pilar; de las Heras, Natalia; Vanegas, Raúl J.; Gutiérrez, Norma C.; Hernández-Rivas, Jesús M. (European journal of haematology, 2012)
Keywords: Adult; Aged; Aged, 80 and over; Antineoplastic Agents - administration & dosage; Antineoplastic Agents - therapeutic use; atypical CML (aCML); Benzamides; Bone Marrow Neoplasms - drug therapy; Bone Marrow Neoplasms - epidemiology; Bone Marrow Neoplasms - genetics; chronic myelomonocytic leukaemia (CMML); cytogenetics; Female; fluorescence in situ hybridisation (FISH); Follow-Up Studies; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Incidence; Male; Middle Aged; Myeloproliferative Disorders - drug therapy; Myeloproliferative Disorders - epidemiology; Myeloproliferative Disorders - genetics; myeloproliferative neoplasms (MPNs); PDGFRB rearrangement; Piperazines - administration & dosage; Piperazines - therapeutic use; Protein Kinase Inhibitors - administration & dosage; Protein Kinase Inhibitors - therapeutic use; Pyrimidines - administration & dosage; Pyrimidines - therapeutic use; Receptor, Platelet-Derived Growth Factor beta - genetics; Translocation, Genetic; Treatment Outcome